Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNeedle anxiety before a first Mounjaro injection is common enough that clinical trial teams built specific support around it. If you're nervous about injecting yourself, you're in good company — and the evidence suggests the worry is almost always worse than the act itself. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins, and our team is available to answer exactly these questions.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, ran for 72 weeks and involved 2,539 adults, nearly all of whom were injecting a GLP-1 or GIP/GLP-1 medicine for the first time. Dropout rates attributable to the injection method itself were low. That's not a coincidence. The KwikPen is designed so the needle is concealed inside the cap and automatically retracts after injection; there is no syringe to draw up, no visible needle to cap, and no plunger to push. You press the pen against skin, press the button, and hold for ten seconds. That's the mechanical reality, which tends to land differently than the imagined one.
Needle anxiety is a well-recognised response, not a character flaw, and it doesn't go away by willpower alone. What does help is information, repetition and a setup that removes as many surprises as possible. The guidance published by the NHS on tirzepatide encourages patients to read the Patient Information Leaflet carefully before their first dose and to contact their prescriber if they have questions about the injection process.
One thing our prescribers hear regularly: people say they sat with the pen for twenty minutes on dose one, then were done in thirty seconds. That gap between anticipation and reality is where most of the anxiety lives.
Temperature matters more than most people realise. Injecting a pen taken straight from the fridge tends to sting more than one that has been left at room temperature for around 30 minutes beforehand, check the Patient Information Leaflet for the exact window permitted for your pen, since the allowable time out of refrigeration is specified there and you shouldn't exceed it.
Site selection also helps. The abdomen (roughly an inch either side of the navel) is where most people start. It has a thicker layer of subcutaneous fat, which means the injection typically causes less sensation than the upper arm. The guide to Mounjaro injection sites on this site covers the three licensed locations in detail, including how to rotate them across doses.
Pinching the skin gently before inserting the pen, breathing out slowly as you press the button, and keeping the pen still for a full ten seconds all reduce the chance of leakage or discomfort. Clean the site first, alcohol swabs are a simple way to build a consistent pre-injection routine, which itself reduces anxiety by making each dose feel less novel.
Technique questions are answered in full on the step-by-step Mounjaro injection page. If you're still unsure after reading, our prescribers are reachable seven days a week.
Some redness, mild swelling or a small lump at the injection site after a dose is normal and typically settles within a few hours to a day. Rotating sites with every dose (so the same spot isn't used two weeks running) is the main way to prevent cumulative irritation.
Persistent redness, a site that's warm and swollen for more than a day or two, or any reaction that spreads beyond the injection area should be reported to your prescriber. The full picture of what's expected versus what warrants attention is covered on the Mounjaro injection site redness page. Any suspected side effect can also be reported to the MHRA via the Yellow Card scheme.
Serious allergic reactions to tirzepatide are rare but possible, difficulty breathing, swelling of the face or throat, or a fast heartbeat after an injection require immediate emergency care. This is different from the localised skin reactions most people experience, and knowing the difference in advance is genuinely reassuring rather than alarming.
If you've had past reactions to injectable medicines, tell your prescriber before starting. That's exactly the kind of history that a clinical review of Mounjaro suitability is designed to surface.
Dose two is almost universally less stressful than dose one. By dose four most people describe the weekly injection as unremarkable, roughly in the same mental category as taking a tablet. The consistency of a fixed weekly day helps; some people find it useful to pair the injection with a regular weekly event so it becomes habit rather than decision.
The question of when to take each Mounjaro dose is worth settling early. Any consistent day each week is fine; stability matters more than the specific day chosen.
If you're at the stage of weighing up whether Mounjaro is right for you, the weight-loss treatment overview lays out the options without pressure. Cost context (including what a private prescription typically involves) is covered on the getting Mounjaro online page if that's a question on your mind too. When you're ready to talk through the clinical side with a prescriber, the free consultation is the right place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.